Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Boss

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Clinical Pharmacology|April 22, 2010
Inducing synthetic lethality using PARP inhibitorsDavid S Boss, Jos H Beijnen, Jan H M Schellens
The Oncologist|August 18, 2009
Clinical experience with aurora kinase inhibitors: a reviewDavid S Boss, Jos H Beijnen, Jan H M Schellens
Journal of Patient Safety|April 9, 2025
Antecedents and Outcomes of Physician Coworker Conflict: A Differential Occupational Model for Health Care ManagersEung Il Kim, Benjamin B Dunford, Wayne Boss, et al.
Family Practice|October 4, 2017
Influence of point-of-care C-reactive protein testing on antibiotic prescription habits in primary care in the NetherlandsTim J Schuijt, David S Boss, Ruben E A Musson, et al.
Health Care Management Review|December 21, 2017
Work-family culture within hospitals: An interdepartmental analysis of employee engagement and retentionMatthew B Perrigino, Benjamin B Dunford, Matt Troup, et al.
The Oncologist|February 5, 2008
Application of PET/CT in the development of novel anticancer drugsDavid S Boss, Renato Valdes Olmos, Michiel Sinaasappel, et al.
Interactive Cardiovascular and Thoracic Surgery|August 3, 2007
Malondialdehyde in plasma, a biomarker of global oxidative stress during mini-CABG compared to on- and off-pump CABG surgery: a pilot studyWim B Gerritsen, Wim-Jan P van Boven, David S Boss, et al.
Tumori|May 3, 2011
Serum beta-HCG and CA-125 as tumor markers in a patient with osteosarcoma: case reportDavid S Boss, Hilary Glen, Jos H Beijnen, et al.
Analytical Biochemistry|May 26, 2009
Development and validation of an enzyme-linked immunosorbent assay for the quantification of trastuzumab in human serum and plasmaCarola W N Damen, Els R de Groot, Marianne Heij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2009
Phase I pharmacokinetic and pharmacodynamic study of Carboplatin and topotecan administered intravenously every 28 days to patients with malignant solid tumorsDavid S Boss, Wandena S Siegel-Lakhai, Nadja E van Egmond-Schoemaker, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Clinical Pharmacology|April 22, 2010
Inducing synthetic lethality using PARP inhibitorsDavid S Boss, Jos H Beijnen, Jan H M Schellens
The Oncologist|August 18, 2009
Clinical experience with aurora kinase inhibitors: a reviewDavid S Boss, Jos H Beijnen, Jan H M Schellens
Journal of Patient Safety|April 9, 2025
Antecedents and Outcomes of Physician Coworker Conflict: A Differential Occupational Model for Health Care ManagersEung Il Kim, Benjamin B Dunford, Wayne Boss, et al.
Family Practice|October 4, 2017
Influence of point-of-care C-reactive protein testing on antibiotic prescription habits in primary care in the NetherlandsTim J Schuijt, David S Boss, Ruben E A Musson, et al.
Health Care Management Review|December 21, 2017
Work-family culture within hospitals: An interdepartmental analysis of employee engagement and retentionMatthew B Perrigino, Benjamin B Dunford, Matt Troup, et al.
The Oncologist|February 5, 2008
Application of PET/CT in the development of novel anticancer drugsDavid S Boss, Renato Valdes Olmos, Michiel Sinaasappel, et al.
Interactive Cardiovascular and Thoracic Surgery|August 3, 2007
Malondialdehyde in plasma, a biomarker of global oxidative stress during mini-CABG compared to on- and off-pump CABG surgery: a pilot studyWim B Gerritsen, Wim-Jan P van Boven, David S Boss, et al.
Tumori|May 3, 2011
Serum beta-HCG and CA-125 as tumor markers in a patient with osteosarcoma: case reportDavid S Boss, Hilary Glen, Jos H Beijnen, et al.
Analytical Biochemistry|May 26, 2009
Development and validation of an enzyme-linked immunosorbent assay for the quantification of trastuzumab in human serum and plasmaCarola W N Damen, Els R de Groot, Marianne Heij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2009
Phase I pharmacokinetic and pharmacodynamic study of Carboplatin and topotecan administered intravenously every 28 days to patients with malignant solid tumorsDavid S Boss, Wandena S Siegel-Lakhai, Nadja E van Egmond-Schoemaker, et al.
Pageof 2